Patent · US Active

1, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases

US9023852B2 · kind B2 · utility

2Cited by

0References

22Claims

0Family size

Assignee

ReMYND N.V. · BE

Inventors

Gerard Griffioen · Linden, BE
Matthias Nettekoven · Weil am Rhein, DE
Katrien Princen · Heverlee, BE
Hasane Ratni · Habsheim, FR
Walter Vifian · Gelterkinden, CH

Key dates

Filing date	Jun 29, 2012
Grant date	May 5, 2015
Priority date	—
Expiry date	Jun 29, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula (IA) The present invention also relates to the use of the compound of formula IA for treating certain neurodegenerative disorders characterized by cytotoxic TAU misfolding and/or aggregation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.